Navigation Links
GrabIt™ Protein G Plus/Protein A Kit from Novagen

ProductsGrabIt™ Protein G Plus/Protein A Kit from Novagen
Company Novagen
Item GrabIt™ Protein G Plus/Protein A Kit
Price $277.00
Description The GrabIt™ Kits are designed for the study of protein:protein interactions from eukaryotic cells using a pull-down method. Proteins that interact with GST•Tag™, S•Tag™, or T7•Tag® fusion proteins are copurified using affinity resins for the tags, and the complexes are retained on a spin filter. The complexes are eluted with sample buffer in preparation for SDS-polyacrylamide gel electrophoresis. An additional kit based on the more traditional immunoprecipitation method relies on Protein G and Protein A agarose for the capture. The GrabIt kits provide enough CytoBuster™ Protein Extraction Reagent, specific resin, wash buffer, spin filters with receiver tubes, and 4x SDS sample buffer for 50 purifications.
Info NovagenNovagen
441 Charmany Drive
Madison, WI 53719
Customer Service: 800-526-7319
Tech Support: 800-207-0144
Fax Number: 608-238-1388
Web Site: http://www.novagen.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Mouse Anti-Protein S Monoclonal Antibody, Unconjugated, Clone HYB 232-02 from Abcam
2. S-Protein Agarose from Novagen
3. Rabbit Anti-Human Vitamin K-dependent Protein S (PROS1) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
4. S-Protein Agarose from Novagen
5. S-Protein Agarose from Novagen
6. Standard Protein Kinase Substrate (PKS) Peptide Microarray from LC Sciences
7. Protein 295 ex from HORIBA Jobin Yvon
8. ProteomeLab PA 800 Protein Characterization System from Beckman Coulter
9. ProteomeLab PF 2D Protein Fractionation System from Beckman Coulter
10. Protein Kinase Substrate (PKS) Peptide Microarray - Comprehensive Service from LC Sciences
11. Imaging Mass Spectrometry for Small Molecule Localization from Protein Discovery, Inc.
(Date:2/5/2015)... DIEGO , Jan. 26, 2015   Epic Sciences ... of cancer, today announced that Murali Prahalad , Ph.D., ... Personalized Medicine World Conference (PMWC) 2015: Silicon Valley, which ... Mountain View, Calif. on January 26-28, 2015. ... "CTCs Come of Age as Biomarkers." Last year, Epic Sciences ...
(Date:2/5/2015)... SAN FRANCISCO , January 28, 2015 ... Camera Market Analysis, Size And Segment Forecasts To 2020 ... The global IR camera market is expected to reach ... study by Grand View Research, Inc. IR cameras help ... injuries, and are expected to witness surging demand in ...
(Date:2/5/2015)... , Jan. 30, 2015  It is gratifying to ... and potential for genomic science as a means to ... prevention and treatment.  I was honored to participate in ... precision medicine program. Since the 1980s ... of genomics—from the first sequenced genome of a free ...
Breaking Biology News(10 mins):Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2
... , Every year the approach of flu season sets off ... are many different strains of flu and they vary from ... educated guess and tell manufacturers which variants of the flu ... works, flu-related illnesses can kill 3,000 to 49,000 Americans annually, ...
... the Polytechnic Institute of New York University (NYU-Poly) and ... carrier in their lab that is five times more ... delivery methodsreagent vectors. This novel complex is a peptide-polymer ... are used to carry DNA into cells. ...
... is a devastating illness that gradually robs sufferers of muscle ... drug available to treat the disease extends life spans by ... study published in Nature Genetics , University of Pennsylvania ... which ALS acts. Working with a powerful fruit fly model ...
Cached Biology News:Stanford researchers take a step toward developing a 'universal' flu vaccine 2Stanford researchers take a step toward developing a 'universal' flu vaccine 3Stanford researchers take a step toward developing a 'universal' flu vaccine 4Researchers engineer a hybrid 5 times more effective in delivering genetic material into cells 2Penn-led team reduces toxicity associated with Lou Gehrig's disease in animal models 2Penn-led team reduces toxicity associated with Lou Gehrig's disease in animal models 3Penn-led team reduces toxicity associated with Lou Gehrig's disease in animal models 4
(Date:3/2/2015)...  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a leading ... today announced that it will release fourth quarter and ... March 10, 2015 after the close of the U.S. ... and webcast on Tuesday, March 10, 2015 at 4:30 ... results and recent corporate developments. For both ...
(Date:3/2/2015)... Outside GC, the leading provider of on-demand, in-house ... Casey as a member of the firm, further strengthening ... , Debbie has spent over 20 years in the ... North America in both legal and business capacities. ... Outside GC’s growing list of healthcare clients, with a ...
(Date:2/27/2015)... and SUMMERLAND, British Columbia , Feb. ... XON ), a leader in synthetic biology, today ... Okanagan Specialty Fruits (OSF), the pioneering agricultural company ... world,s first non-browning apple. Through the acquisition, Intrexon expands ... is more appetizing and convenient for consumers while providing ...
(Date:2/27/2015)... Nova Scotia (PRWEB) February 27, 2015 ... stage vaccine and immunotherapy company, today announced that ... its application for Fast Track designation and Phase ... vaccines, in conjunction with the mutual co-development agreement ... previously obtained Fast Track designation for the DPX-Survivac. ...
Breaking Biology Technology:Asterias Biotherapeutics to Report Fourth Quarter and Full Year 2014 Results on March 10, 2015 2Outside GC Expands Healthcare Team 2Intrexon to Acquire Okanagan Specialty Fruits 2Intrexon to Acquire Okanagan Specialty Fruits 3Intrexon to Acquire Okanagan Specialty Fruits 4Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3